Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKDSankar D. Navaneethan, Joseph V. Nally, Stacey E. Jolly et al.|Clinical Journal of the American Society of Nephrology|2017Cited by 56
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosisRobert J. Fox, Jens Kühle, Paola Raska et al.|Multiple Sclerosis Journal|2021Cited by 47
Development of a chronic kidney disease patient navigator programStacey E. Jolly, Joseph V. Nally, Sankar D. Navaneethan et al.|BMC Nephrology|2015Cited by 43
Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched AnalysisPulkit Chaudhury, Georges Nakhoul, Sherif Armanyous et al.|The Nephron journals/Nephron journals|2018Cited by 31
Impact of Uric Acid Levels on Kidney Disease ProgressionHernan Rincon-Choles, Michael B. Rothberg, Stacey E. Jolly et al.|American Journal of Nephrology|2017Cited by 27